August 19, 2022 Experience Freeman Spogli investment in EverVet We advised Tailwind Capital and EverVet on the transaction
August 19, 2022 Experience Esco Aster spinoff transactions We are advising Esco Lifesciences on the spinoff
August 11, 2022 Experience InSilico Medicine $35 million Series D2 financing We are advising InSilico Medicine on the financing
August 4, 2022 Experience Gilead Sciences $405 million acquisition of MiroBio We are advising Gilead Sciences on the transaction
August 3, 2022 Experience Taibang Biologic Group $300 million equity raising We are advising Taibang Biologic Group in connection with its equity raising by a group of investors
July 5, 2022 Experience Precigen sale of Trans Ova Genetics to URUS We are advising Precigen on the transaction
July 1, 2022 Experience Acutus Medical sale of its left-heart access portfolio products and refinancing We advised Acutus Medical on the transactions
June 21, 2022 Experience TPG Capital $1.1 billion take-private acquisition of Convey Health Solutions We are advising TPG Capital on the transaction
June 8, 2022 Experience Dynamics Special Purpose Corp. completed combination with Senti Biosciences We advised Dynamics Special Purpose Corp. on this transaction
June 7, 2022 Experience InSilico Medicine $60 million Series D financing We are advising InSilico Medicine in connection with its $60 million Series D financing